SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-11-061642
Filing Date
2011-11-07
Accepted
2011-11-07 16:14:50
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 v239025_s3.htm S-3 458172
2 EXHIBIT 4.8 v239025_ex4-8.htm EX-4.8 493524
3 EXHIBIT 5.1 v239025_ex5-1.htm EX-5.1 35185
4 EXHIBIT 12.1 v239025_ex12-1.htm EX-12.1 61983
5 EXHIBIT 23.1 v239025_ex23-1.htm EX-23.1 3505
6 EXHIBIT 23.2 v239025_ex23-2.htm EX-23.2 3341
7 GRAPHIC img.jpg GRAPHIC 19323
8 GRAPHIC logo.jpg GRAPHIC 8722
  Complete submission text file 0001144204-11-061642.txt   1095711
Mailing Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036
Business Address 1180 AVENUE OF THE AMERICA 19TH FLOOR NEW YORK NY 10036 646-214-0700
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-177793 | Film No.: 111184809
SIC: 8093 Services-Specialty Outpatient Facilities, NEC